Syros Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Syros Pharmaceuticals, Inc. has filed 682 SEC EDGAR filings since 22 Aug 2012

SEC filing history

Showing 501-525 of 682 matching filings.

Per page
25
Current page
21
DEFA14A File 001-37813

DEFA14A

Filing date
26 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37813

DEF 14A

Filing date
26 Apr 2018
Reporting date
14 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-37813

CT ORDER filing

Filing date
24 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37813

8-K

Filing date
15 Mar 2018
Reporting date
12 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
12 Mar 2018
Reporting date
12 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 -

Filing date
12 Mar 2018
Reporting date
12 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-223574

S-8

Filing date
12 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37813

8-K

Filing date
12 Mar 2018
Reporting date
07 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
21 Feb 2018
Reporting date
16 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
21 Feb 2018
Reporting date
16 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
21 Feb 2018
Reporting date
16 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
21 Feb 2018
Reporting date
16 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89552

SC 13G/A filing

Filing date
14 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
5

PRIMARY DOCUMENT

Filing date
13 Feb 2018
Reporting date
31 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89552

SC 13G/A filing

Filing date
13 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-222634

EFFECT filing

Filing date
12 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D/A File 021-303459

D/A filing

Filing date
09 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
08 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-222634

S-3/A

Filing date
07 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89552

ARCH VII - SYROS PHARMACEUTICALS 13GA(#1)

Filing date
02 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-222634

S-3/A

Filing date
02 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37813

8-K

Filing date
02 Feb 2018
Reporting date
02 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Feb 2018
Reporting date
31 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37813

8-K

Filing date
31 Jan 2018
Reporting date
30 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .